Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Debt / NOTE 0.750% 5/1
-
Number of holders
-
0
-
Total 13F principal, excl. options
-
0
-
Principal change
-
-300,000
-
Total reported value, excl. options
-
$0
-
Value change
-
-$298,682
-
Number of sells
-
-1
Significant Holders of LIGAND PHARMACEUTICALS INC - NOTE 0.750% 5/1 as of Q3 2023
1 filing reported holding 53220KAF5 - LIGAND PHARMACEUTICALS INC - NOTE 0.750% 5/1 as of Q3 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.